Matthew Kangas, MD
Interventional Pain Medicine · Memphis, TNNPI 1750674222
Payments from drug & device makers
Across 328 payments — averaging $67.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$9K
- Nevro Corp.$7K
- Boston Scientific$2K
- Medtronic$2K
- Gentleman Orthopedic Solutions$539
- Globus Medical$331
- plus $3K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 100 | $8,726 |
| Nevro Corp. | 70 | $6,723 |
| Boston Scientific | 10 | $1,670 |
| Medtronic | 29 | $1,619 |
| Gentleman Orthopedic Solutions | 4 | $539 |
| Globus Medical | 4 | $331 |
| Arthrex | 4 | $318 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 36 | $310 |
| Amgen | 12 | $253 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $244 |
| Saluda Medical Americas, Inc. | 2 | $224 |
| Relievant Medsystems, Inc. | 3 | $175 |
| Stryker | 4 | $147 |
| Collegium Pharmaceutical, Inc. | 9 | $146 |
| Averitas Pharma Inc. | 6 | $136 |
| Curonix LLC | 1 | $100 |
| Si-bone, Inc. | 2 | $94 |
| Scilex Pharmaceuticals Inc. | 6 | $89 |
| Nalu Medical, Inc. | 2 | $76 |
| Pfizer | 3 | $60 |
| AbbVie | 3 | $52 |
| SPR Therapeutics, Inc | 2 | $51 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Lilly USA, LLC | 2 | $28 |
| Kowa Pharmaceuticals America, Inc. | 1 | $24 |
| IBSA Pharma Inc. | 1 | $22 |
| Vertex | 1 | $18 |
How this compares
$22,210 in reported general payments places this provider in the 90th percentile of 41 interventional pain medicine providers in Tennessee.
See all interventional pain medicine providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Memphis
- Moacir SchnappMemphis$7K
- Cindy TranMemphis$2K
- Kit MaysMemphis$481
- William NewtonWinchester$225K
- Ryan BearerWinchester$35K
- Michael WilkinsonJohnson City$35K
- Jacob MillsMountain Home$24K
- Matthew RupertFranklin$17K
- Adolfo CuadraKnoxville$15K
- Cameron ShawverJohnson City$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.